Pure Global
NCT04093830

Bimodal Stimulation Compared to Unilateral Cochlear Implant

Advantages of Bimodal Stimulation Compared to Unilateral Cochlear Implant Use in Children With Hearing Loss
Assiut University·ClinicalTrials.gov·device·Device trial
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hearing Impaired Children
Drug/Device/Intervention
hearing aid
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2020
End date
Jan 01, 2022
Enrollment
25 participants
Primary outcome

Comparison the audiometric thresholds in bimodal fitting users condition and cochlear implant alone condition,Comparison between speech discrimination score in bimodal fitting condition and cochlear implant alone condition.,Evaluation of speech perception ability in noise under bimodal fitting a condition and cochlear implant alone condition,Comparison of early speech perception in bimodal fitting condition and cochlear implant alone condition,Comparison between the speech reception threshold in bimodal fitting condition and cochlear implant alone condition.

Summary

The majority of studies about bimodal hearing advantages have been conducted on adults but
 scant relevant studies into pediatric users, therefore more comparative studies are required
 to compare the effect of bimodal stimulation to unilateral cochlear implant use in children
 with severe to profound sensori-neural hearing loss .

ICD-10 classifications
Hearing loss, unspecifiedOther hearing lossOther specified hearing lossFamily history of deafness and hearing lossCongenital malformations of ear causing impairment of hearing
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04093830
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04093830 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently status unknown. The study focuses on Hearing Impaired Children. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.